Skip to main content
. 2023 Apr 14;102(15):e33432. doi: 10.1097/MD.0000000000033432

Figure 2.

Figure 2.

Median progression-free survival for patients with PLR ≤ 135.7 was significantly better than those with ≥135.7. PLR = platelet-lymphocyte ratio.